AnaptysBio insider plans sale of 10,694 shares

JOE ANTHONY WARE filed to sell common stock of ANAB through Morgan Stanley Smith Barney LLC Executive Financial Services.

Rhea-AI Filing Summary

JOE ANTHONY WARE filed to sell common stock of ANAB through Morgan Stanley Smith Barney LLC Executive Financial Services. The notice covers 10,694 shares of common stock with an aggregate market value of $718,333.09, expected to be sold on or after July 13, 2026 on NASDAQ. The shares relate to a stock option exercise for cash from the issuer. In the preceding three months, 6,030 shares of common stock were sold on June 30, 2026 for total proceeds of $408,773.70.

Filing Explained

The July 13 filing lists 10,694 shares for sale after a cash-paid option exercise; it does not establish a completed sale or company proceeds.

The July 13 Form 144 lists 10,694 AnaptysBio common shares acquired through a stock-option exercise for cash and designated for sale on July 13, 2026.

The filing’s current state is a listing for sale by the filer; it does not establish that those shares were sold, that the issuer received proceeds, or that AnaptysBio’s common-share count changed.

The same filing separately reports 6,030 common shares sold on June 30, 2026 during the past three months.

Key Figures

Shares to be sold: 10,694 shares Aggregate market value: $718,333.09 Prior 3-month shares sold: 6,030 shares +2 more

5 metrics

Shares to be sold 10,694 shares Common stock covered by the Form 144 notice

Aggregate market value $718,333.09 Market value for 10,694 shares of common stock

Prior 3-month shares sold 6,030 shares Common stock sold on June 30, 2026

Prior 3-month sale proceeds $408,773.70 Total consideration for 6,030 shares sold on June 30, 2026

Planned sale date 07/13/2026 Expected date for sales of the 10,694 shares

Key Terms

Form 144, Stock Option Exercise, aggregate market value

3 terms

Form 144 regulatory

"144: Securities Information Common | Morgan Stanley Smith Barney LLC"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 07/13/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 10694 | 718333.09"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ANAB’s Form 144 filing by JOE ANTHONY WARE disclose?

The filing discloses a proposed sale of 10,694 shares of ANAB common stock with an aggregate market value of $718,333.09, following a stock option exercise, with sales expected on or after July 13, 2026.

How many ANAB shares is JOE ANTHONY WARE planning to sell?

The notice covers a proposed sale of 10,694 shares of ANAB common stock. These shares are associated with a stock option exercise and are expected to be sold for cash through a broker on NASDAQ.

What is the aggregate market value of ANAB shares in this Form 144?

The proposed sale involves ANAB common stock with an aggregate market value of $718,333.09. This amount reflects the market value used for the Form 144 notice covering 10,694 shares planned for sale.

When are the ANAB shares covered by this Form 144 expected to be sold?

The shares are expected to be sold on or after July 13, 2026. The Form 144 indicates NASDAQ as the trading market and identifies the transaction type as a stock option exercise for cash.

What ANAB stock sales has JOE ANTHONY WARE made in the past 3 months?

During the past three months, there was a sale of 6,030 shares of ANAB common stock on June 30, 2026 for total proceeds of $408,773.70, as reported in the Form 144.

Which broker is involved in the ANAB Form 144 transaction?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, which is identified in connection with the proposed sale of ANAB common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 04:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001715429
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ANAPTYSBIO, INC.
SEC File Number	001-37985
Address of Issuer	10770 Wateridge Circle, Suite 210 San Diego CALIFORNIA 92121
Phone	(858) 362-6295
Name of Person for Whose Account the Securities are To Be Sold	JOE ANTHONY WARE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10694	718333.09	29100902	07/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/13/2026	Stock Option Exercise	Issuer			10694	07/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOE ANTHONY WARE 10770 Wateridge Circle, Suite 210 San Diego CA 92121	Common	06/30/2026	6030	408773.70

144: Remarks and Signature

Remarks
Date of Notice	07/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joe Anthony Ware
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)